Brugada pattern exposed with administration of amiodarone during emergent treatment of ventricular tachycardia.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
02 2019
Historique:
received: 14 05 2018
revised: 21 10 2018
accepted: 23 10 2018
pubmed: 13 11 2018
medline: 23 10 2019
entrez: 13 11 2018
Statut: ppublish

Résumé

Brugada pattern is a well-known pathological finding on electrocardiogram (ECG) which increases the likelihood of cardiac arrest due to ventricular arrhythmia. These cases generally present in younger patients without evidence of an electrolyte abnormality, structural heart disease, or cardiac ischemia. In many instances, this pattern is either hidden on initial presentation or presents as an incidental finding on an EKG. Often times the Brugada syndrome leads to sudden cardiac death or more rarely can be unmasked with a class 1A or 1C anti-arrhythmic agent. Here, we present a distinctive case in which the pattern was exposed by amiodarone during the emergent treatment of Ventricular Tachycardia (VT). A 34-year-old female, without significant cardiac history, presented to the Emergency Department after multiple near syncopal episodes at home. Initial ECG showed VT vs. SVT. After a failed trial of adenosine, the patient was treated with 150 mg amiodarone and became hypotensive needing an electrical cardioversion. After becoming bradycardic, the amiodarone drip was discontinued and she was admitted to the MICU. An echocardiogram and left heart catheterization showed no evidence of coronary artery disease or decreased ejection fraction. The patient's ECG now showed a subtle Brugada Type 3 pattern and she received a dual chamber AICD upon discharge. This case emphasizes the awareness needed to seek out this pattern on subsequent ECG's. With the high lethality of Brugada, the emergency physician must recognize that multiple drugs can evoke this pattern after initial presentation.

Sections du résumé

BACKGROUND
Brugada pattern is a well-known pathological finding on electrocardiogram (ECG) which increases the likelihood of cardiac arrest due to ventricular arrhythmia. These cases generally present in younger patients without evidence of an electrolyte abnormality, structural heart disease, or cardiac ischemia. In many instances, this pattern is either hidden on initial presentation or presents as an incidental finding on an EKG. Often times the Brugada syndrome leads to sudden cardiac death or more rarely can be unmasked with a class 1A or 1C anti-arrhythmic agent. Here, we present a distinctive case in which the pattern was exposed by amiodarone during the emergent treatment of Ventricular Tachycardia (VT).
CASE REPORT
A 34-year-old female, without significant cardiac history, presented to the Emergency Department after multiple near syncopal episodes at home. Initial ECG showed VT vs. SVT. After a failed trial of adenosine, the patient was treated with 150 mg amiodarone and became hypotensive needing an electrical cardioversion. After becoming bradycardic, the amiodarone drip was discontinued and she was admitted to the MICU. An echocardiogram and left heart catheterization showed no evidence of coronary artery disease or decreased ejection fraction. The patient's ECG now showed a subtle Brugada Type 3 pattern and she received a dual chamber AICD upon discharge.
CONCLUSION
This case emphasizes the awareness needed to seek out this pattern on subsequent ECG's. With the high lethality of Brugada, the emergency physician must recognize that multiple drugs can evoke this pattern after initial presentation.

Identifiants

pubmed: 30415983
pii: S0735-6757(18)30864-7
doi: 10.1016/j.ajem.2018.10.050
pii:
doi:

Substances chimiques

Anti-Arrhythmia Agents 0
Amiodarone N3RQ532IUT

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

376.e3-376.e7

Informations de copyright

Published by Elsevier Inc.

Auteurs

Douglas Robinson (D)

Carl R. Darnall Army Medical Center, Emergency Medicine Residency, 36065 Santa Fe Ave, Fort Hood, TX 76544, United States of America. Electronic address: Douglas.Robinson@rvu.edu.

Gregory Hand (G)

Carl R. Darnall Army Medical Center, Emergency Medicine Residency, 36065 Santa Fe Ave, Fort Hood, TX 76544, United States of America. Electronic address: gregory.r.hand2.mil@mail.mil.

Jason Ausman (J)

Carl R. Darnall Army Medical Center, Emergency Medicine Residency, 36065 Santa Fe Ave, Fort Hood, TX 76544, United States of America.

Anthony Hackett (A)

Carl R. Darnall Army Medical Center, Emergency Medicine Residency, 36065 Santa Fe Ave, Fort Hood, TX 76544, United States of America. Electronic address: ahackett@nyit.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH